| |
Forbes Medi-Tech Inc.
The strategy and vision of Forbes Medi-Tech Inc. is to develop and market a portfolio of nutraceutical products, including functional foods and supplements, for the benefit of all consumers. An increasingly active population, the pursuit of healthier lifestyles and the desire to live longer have given rise to a category of products known as nutraceuticals. This category includes functional foods, which are conventional foods containing ingredients that provide additional health or nutritional benefits leading to possible risk reduction of contracting chronic diseases.
Since the Company's inception in 1992, Forbes has made important technological advances in the development of innovative sterol-based products that offer significant commercial opportunities. Reducol™ is a clinically proven cholesterol-lowering ingredient for use in functional foods and dietary supplements. In May 2008, Forbes announced its strategy to focus on its nutraceutical business areas and leverage its core competencies:
Competitive advantage through technology: Proprietary technologies provide Forbes with product or process advantages over existing competition.
Targeting significant markets: Forbes focuses the development of its technology and products within markets that offer significant potential. Each of its target markets currently represents a multi-billion dollar global market.
Commercialization through strategic partnerships and business associations: The Company believes that leveraging its technology through strategic partnerships and business associations will accelerate commercialization and maximize the chances of success.
| | 
| |
